ABNORMAL DISTRIBUTION OF THE NON-A-BETA COMPONENT OF ALZHEIMERS-DISEASE AMYLOID PRECURSOR ALPHA-SYNUCLEIN IN LEWY BODY DISEASE AS REVEALED BY PROTEINASE-K AND FORMIC-ACID PRETREATMENT/
A. Takeda et al., ABNORMAL DISTRIBUTION OF THE NON-A-BETA COMPONENT OF ALZHEIMERS-DISEASE AMYLOID PRECURSOR ALPHA-SYNUCLEIN IN LEWY BODY DISEASE AS REVEALED BY PROTEINASE-K AND FORMIC-ACID PRETREATMENT/, Laboratory investigation, 78(9), 1998, pp. 1169-1177
Citations number
50
Categorie Soggetti
Pathology,"Medical Laboratory Technology","Medicine, Research & Experimental
The precursor of the non-A beta component of Alzheimer's disease amylo
id (NACP) (also known as alpha-synuclein) is a presynaptic terminal mo
lecule that abnormally accumulates in the plaques of Alzheimer's disea
se (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffu
se Lewy body disease, and Parkinson's disease. To better understand th
e distribution of NACP/alpha-synuclein and its fragments in the LB-bea
ring neurons and neurites, as well as to clarify the patterns of NACP/
(alpha-asynuclein compartmentalization, we studied NACP/a-synuclein im
munoreactivity using antibodies against the C-terminal, N-terminal, an
d NAC regions after Proteinase K and formic acid treatment in the cort
ex of patients with LBs. Furthermore, studies of the subcellular local
ization of NACP/alpha-synuclein within LB-bearing neurons were perform
ed by immunogold electron microscopy. These studies showed that the N-
terminal antibody immunolabeled the LBs and dystrophic neurites with g
reat intensity and, to a lesser extent, the synapses. In contrast, the
G-terminal antibody strongly labeled the synapses and, to a lesser ex
tent, the LBs and dystrophic neurites. Whereas Proteinase K treatment
enhanced NACP/alpha-synuclein immunoreactivity with the G-terminal ant
ibody, it diminished the N-terminal NACP/a-synuclein immunoreactivity.
Furthermore, formic acid enhanced LB and dystrophic neurite labeling
with both the C- and N-terminal antibodies. In addition, whereas witho
ut pretreatment only slight anti-NAG immunoreactivity was found in the
LBs, formic acid pretreatment revealed an extensive anti-NAG immunost
aining of LBs, plaques, and glial cells. Ultrastructural analysis reve
aled that NACP/alpha-synuclein immunoreactivity was diffusely distribu
ted within the amorphous electrodense material in the LBs and as small
clusters in the filaments of LBs and neurites. These results support
the view that aggregated NACP/alpha-synuclein might play an important
role in the pathogenesis of disorders associated with LBs.